🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSingapore HSA regulations — 12 month update Page 2

Singapore HSA regulations — 12 month update

quinn_sf Sun, Jun 16, 2024 at 1:49 PM 36 replies 2,367 viewsPage 2 of 8
mona_PHX
Member
189
890
Dec 2024
Phoenix, AZ
Jun 16, 2024 at 4:39 PM#6

This is super helpful. So the bottom line is: if I want the smoothest experience, I should find a 503B outsourcing facility that's licensed in my state, rather than trying to use a local 503A pharmacy?

Last edited: Jun 16, 2024 at 7:39 PM
50 21RetaRick_CA, JenPlateau, SallyK_inj and 47 others
Reply Quote Save Share Report
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Jun 16, 2024 at 4:56 PM#7

Generally yes, for GLP-1 peptides specifically. 503B facilities have the federal registration that smooths over most state-to-state issues. Just verify they're licensed in your state before placing an order — most will list their state licenses on their website.

And keep in mind this landscape changes constantly. What's true today might not be true in 6 months, especially with FDA enforcement actions ramping up.

Last edited: Jun 16, 2024 at 10:56 PM
30 19EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 27 others
Reply Quote Save Share Report
RetaRick_CA
VIP Member
2,012
9,876
Jan 2024
California
Jun 16, 2024 at 5:13 PM#8

One more thing — regardless of which state you're in, always check the FDA's list of registered outsourcing facilities. If a 503B claims to be registered but isn't on that list, that's a major red flag. The list is publicly available and searchable. Takes 2 minutes to verify. 📋

15 9DadBodDave, AmyNC_wife, SkepticalSean and 12 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register